Additional file 2 of Improvement of renal function after transcatheter aortic valve replacement and its impact on survival

Additional file 2: Supplementary figure 1. Kaplan-Meier-Estimates of survival in patients with (blue line) and without (red line) renal improvement in propensity stratum 1. Supplementary figure 2. Kaplan-Meier-Estimates of survival in patients with (blue line) and without (red line) renal improvement in propensity stratum 2. Supplementary figure 3. Kaplan-Meier-Estimates of survival in patients with (blue line) and without (red line) renal improvement in propensity stratum 3. Supplementary figure 4. Kaplan-Meier-Estimates of survival in patients with (blue line) and without (red line) renal improvement in propensity stratum 4. Supplementary figure 5. Kaplan-Meier-Estimates of survival in patients in propensity strata 1 to 4 (blue line) and in propensity stratum 5 (red line) among the subgroup of patients without renal improvement. Supplementary figure 6. Kaplan-Meier-Estimates of survival in patients in propensity strata 1 to 4 (blue line) and in propensity stratum 5 (red line) among the subgroup of patients with renal improvement. Supplementary figure 7. Kaplan-Meier-Estimates of survival in patients with (dashed lines) and without (solid lines) renal improvement, separately for all 5 propensity strata (stratum 1: black, stratum 2: green, stratum 3: blue, stratum 4: grey, stratum 5: red). Supplementary figure 8. Kaplan-Meier-Estimates of survival in patients with (blue line) and without (red line) renal improvement among the subgroup of patients with NYHA II. Supplementary figure 9. Kaplan-Meier-Estimates of survival in patients with (blue line) and without (red line) renal improvement among the subgroup of patients with NYHA III. Supplementary figure 10. Kaplan-Meier-Estimates of survival in patients with (blue line) and without (red line) renal improvement among the subgroup of patients with baseline NT-proBNP values in the first to third quartile.